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Prostate cancer is one of the most common malignant neoplasms among 
men in Western countries (De Marzo et al. 2017). In 2020, there will be an 
estimated 191,930 American men diagnosed with prostate cancer, an almost 10% 
increase from 2019 (Siegel et al. 2020). Visual resources for understanding of the 
pathogenesis of prostate cancer development, and specifically the development of 
prostate cancer precursor lesions, are limited. A visual void exists between 
prostate cancer Pathologists presenting histological findings and those with 
differing prostate cancer specialties. Furthermore, prostate cancer is typically 
studied using two-dimensional microscopy slides, and it is often difficult to 
explain new three-dimensional spatial hypotheses and findings to those outside 
of the pathology field.  
Recent pathological evidence suggests a new role for prostate infections 
and inflammation in prostate cancer development. This novel hypothesis has the 
potential to challenge the dogma that high grade prostatic intraepithelial 
neoplasia (HGPIN) serves as the direct precursor to prostate cancer 
development. Rather, new molecular pathologic evidence indicates that an 
inflammation-associated lesion termed proliferative inflammatory atrophy (PIA) 
may directly transition to prostate cancer. 3D visualization of prostate cancer is 
novel and important in itself due to the multi-focal and atypical pattern of 
growth, and it is consequently challenging to communicate this new prostate 
cancer precursor lesion development model.  
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To address the lack of comprehensive histological research representation, 
a 3D mechanism of disease animation was constructed which portrays a new 
proposition for precursor lesion development using novel radical prostatectomy 
specimen data. The animation outlines and describes the harmful effects inflicted 
upon luminal epithelium caused by bacterial toxins, such as colibactin, as well as 
oxidants produced by immune cells induced by chronic inflammation. By 
improving visual understanding of histological data, this 3D animation provides a 
platform to further clarify the current knowledge of prostate cancer in the context 
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Overview of the Prostate 
The word ‘prostate’ is derived from Greek word prostates which means 
“protector” or “someone who stands before someone or something,” (Sfanos et al. 
2017). The prostate is a small walnut-sized organ that sits between the bladder 
and the penis, along with the majority of the male reproductive system including 
the epididymis, testicles, and vas deferens (Sfanos et al. 2017). The average size of 
the prostate is 3.4 cm in length, 4.4 cm in width, and 2.6 cm in thickness, with a 
weight ranging from 15 to 20 grams (Amis, 1994). The orientation of the prostate 
is determined by the superior most portion, known as the base, and the inferior 
most portion, known as the apex. The adult prostate is traversed by paired 
ejaculatory ducts that enter the prostate superiorly where they join the prostatic 
urethra about midway to the center of the prostate (Amis, 1994).  
The prostate is composed of five zones that use the prostatic urethra as the 
reference point: the central zone, anterior fibromuscular zone, transition zone, 
peripheral zone, and periurethral zone. The central zone encompasses the 
posterior superior region of the prostate that surrounds the ejaculatory ducts 
(Aaron et al. 2017). The central zone composes roughly 25% of the glandular 
prostate and branches laterally near the prostatic base (McNeal, 1981). The 
lateral borders of the central zone fuses with the proximal peripheral zone border 
to continue its region with the peripheral zone (McNeal, 1981). The anterior 
fibromuscular zone covers the anterior surface of the prostate, protecting the 
prostate with thick connective tissue (McNeal, 1981). The anterior fibromuscular 
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zone extends from the base to the apex. The transition zone lies just posterior to 
the anterior fibromuscular zone and accounts for about 5% of total prostatic 
volume in a normal, non-diseased prostate (McNeal, 1981). The transition zone 
surrounds the anterior portion of the prostatic urethra and is the main site for the 
location of benign prostatic hyperplasia (BPH) pathogenesis (Aaron et al. 2017). 
The peripheral zone surrounds the entire posterolateral surface of the prostate 
and extends anteriorly until meeting with the anterior fibromuscular stroma 
(Amis, 1994). Constituting more than 70% of glandular tissue in the prostate, the 
peripheral zone surrounds the posterior region of the central zone, spanning 
from the base to the apex of the prostate (McNeal, 1981). The majority of prostate 
cancer (75-80%) occurs in the peripheral zone and the remaining cancers arise 
from the transition zone and, rarely, the central zone (McNeal et al. 1988). The 
periurethral zone is the region within the prostate that wraps around the entirety 
of the prostatic urethra, spanning from the superior portion of the prostatic 













Histology of the Prostate 
The zones of the prostate are composed of stroma, or fibromuscular tissue 
containing ductal networks. Ductal networks within the stroma are known as 
glands. Prostatic glands are composed of pseudostratified luminal epithelial cells 
that have direct contact with the lumen of the gland (Figure 1). Supporting the 
luminal epithelium are basal cells. Basal epithelium has direct contact with the 
stroma and is not present in the lumen of the gland. Both luminal and/or basal 
cell types provide implications for tumor stratification and have been intensively 
studied for prostate cancer origin (Wang et al. 2015).  
 
Figure 1. Luminal Epithelium Histology. These microscope slide images 
display the histology of the prostate (De Marzo et al. 2007). 
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Luminal cells line the epithelium and express androgen receptors (AR) 
and produce secretory proteins such as prostate-specific antigens (PSA) and 
prostatic acid phosphatase (PAP) (Zhang et al. 2019). There is strong evidence 
that luminal cells are the cell of origin for prostate tumors, including shared 
genetic and epigenetic alterations such as GSTP1 methylation, telomere 
shortening, and MYC overexpression, in luminal cells in the presumed prostate 
cancer precursor lesion prostatic intraepithelial neoplasia (PIN) and cancer cells 
(Strand et al. 2015; Trabzonlu et al. 2018).  When luminal cells reproduce, they 
are highly plastic in their differentiation capability (Horton et al. 2019).  
Basal cells create the basement structure of the prostatic gland, composing 
a thin sheet of simple squamous cells forming a barrier between the luminal 
epithelium of the gland and the fibromuscular stroma. Proliferation of basal cells 
in the prostate varies from carcinoma to hyperplasia, but carcinoma arising from 
basal cells is exceedingly rare (Shibuya et al. 2018).  
The stromal tissue of the prostate is composed of myofibroblasts, 
endothelial cells, fibroblasts, and immune cells (Krušlin et al. 2015). Collagens, 
elastic fibers, and laminins are also crucial components to stromal integrity. 
Collagens are fibrillar proteins that are important to cellular signaling processes 
and metabolism throughout the prostate (Krušlin et al. 2015). Elastic fibers aid in 
tissue flexibility and play a role in tumor invasion, but its exact role is not entirely 
understood (Krušlin et al. 2015). Laminins are molecules that reside primarily in 
basement membranes (Krušlin et al. 2015). Some research has shown a dramatic 
decrease in laminin expression in the stroma surrounding prostate carcinoma as 
compared to other regions of prostatic tissue (Tomas et al. 2006).  
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Corpora amylacea (CA) are a common occurrence within prostate glands 
and often seen when studying prostate cancer histology under the microscope. 
Corpora amylacea are small laminated bodies that can vary in size from a few 
millimeters to several centimeters in diameter (Sfanos et al. 2009). Prostatic 
calculi (PC), or calcified stones, can also be observed within the lumen and are 
related to corpora amylacea (Sfanos et al. 2009). The presence of CA/PC have 
been observed in prostate specimens with focal acute and chronic inflammation, 
gland occlusions, and epithelial trauma, and are thought to form during acute 


















 Prostate cancer is one of the most common malignant neoplasms among 
men in Western countries (De Marzo et al. 2007). Prostate cancer is most 
common among men over the age of 65 and is prevalent in men of African 
descent (Kooh et al. 2019). Prostatic adenocarcinoma is primarily composed of 
malignancy in the epithelial cells and invasion of the surrounding stroma 
(Krušlin et al. 2015). Recently, a new hypothesis for prostate cancer precursor 
lesion development has been proposed, with a primary focus on the effects of the 
microenvironment and associated chronic inflammation within the prostate (De 
Marzo et al. 2007).  
Chronic and recurrent inflammation have been linked to the pathogenesis 
of prostate cancer development (Nelson et al. 2012). The human urinary 
microbiome, and specifically urinary pathogens that can initiate prostate 
infections, have been proposed to influence the development of prostate cancer 
precursor lesions through direct and indirect interactions (Porter et al. 2018). 
The exact causes of prostate cancer are not well understood, but substantial 
evidence from various areas of cancer study point to multiple factors including 
diet, smoking, obesity, and environmental exposures contributing to 
development.  
   
Inflammation 
 Approximately 20% of human adult cancers are a result from chronic 
inflammation and/or chronic inflammatory states (De Marzo et al. 2007). Not 
only is inflammation observed in prostate cancers, but it is observed in other 
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cancers associated with: stomach, large intestine, lung, pancreas, and esophageal 
cancers (De Marzo et al. 2007). The occurrence of prostatic inflammation within 
the male population is also associated with race and the geographical location of 
cancer patients (Sfanos et al. 2014). Biopsy specimens with chronic inflammation 
have shown to be more common in African American men than in European 
American men (Sfanos et al. 2014).  
Inflammation within the prostate has been hypothesized to be a 
contributor to cancer development due to the frequent observation of 
inflammatory cells in the prostatic microenvironment of men (Sfanos et al. 2018). 
Chronic inflammation has been linked to the development of precursor lesions 
known as proliferative inflammatory atrophy (PIA) within the prostate (De 
Marzo et al. 2007). PIA lesions are classified as central areas of epithelial atrophy 
containing proliferative epithelial cells that are proposedly regenerative in nature 
(Nelson et al. 2003). The frequent findings of PIA lesions in prostate specimens 
exposed to chronic inflammation may be a consequence of inflammatory 
oxidants (Nelson et al. 2003). The contribution of inflammation can be seen in 
histological analysis of adult prostates removed for the treatment of both cancer 
and benign prostatic diseases (Sfanos et al. 2018).  
The persistent presence of inflammatory cells in the prostate may produce 
large amounts of microbicidal oxidants (Nelson et al. 2003). Inflammatory cells 
are known to secrete cytokines which increase epithelial cell proliferation, 
increasing the risk of mutation. With chronic persistence of inflammatory cells 
within the prostate glands, mutations are more likely to occur as epithelial cells 
proliferate (De Marzo et al. 2007).  
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Microbiome 
Recently, the urinary microbiome and prostate infections have been the 
prime subject of investigation in understanding the pathogenesis of prostate 
cancer precursor lesions (Shrestha et al. 2018; Peiffer et al. 2019). In the human 
body, microbes affect a large amount of pathophysiological processes (Kovacs et 
al. 2020; Manzoor et al. 2017). Any change in the quantity or composition of the 
microbiome can be associated with diseases (Kovacs et al. 2020). The urinary 
tract is an example of such interactions between the microbiota and the host 
(Manzoor et al. 2017).  
Approximately 50% of men will have experienced some degree of 
prostatitis in their lifetime (Lupo et al. 2019). Bacteria colonize the prostate via 
ascension of the urethra to cause urinary tract infections (UTI) (Lupo et al. 2019). 
The prostate likely does not contain commensal microbial flora, but rather the 
prostate is populated by microorganisms in a pathological manner with focal 
regions associated with acute or chronic inflammation (Sfanos et al. 2017; Sfanos 
et al. 2008). Pathogenic organisms may also be contracted into the prostate via 
the urethra including sexually transmitted diseases, such as gonorrhea, 
chlamydia, Trichomonas vaginalis, and Treponema pallidum (De Marzo et al. 
2007).  
 In a normal functioning prostate, the prostatic fluid contains elevated 
levels of antimicrobial components such as zinc, citrate, and antimicrobial 
peptides to prevent infection (Sfanos et al. 2017). Hypothetically, the healthy 
human prostate contains little to no organisms, which are not pro-inflammatory 
when the lumen epithelial layer is intact and with normal amounts of 
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antimicrobial secretions (Sfanos et al. 2017). As pathogenic bacteria migrate to 
the lumen of the prostate glands, a robust inflammatory response occurs, which 
is likely concurrent with the development of prostatic atrophy (Sfanos et al. 
2017). The integrity of the luminal epithelial barrier may become disrupted as a 
result of inflammatory cell disruption of the cell layers, allowing bacteria to 
invade the stroma and surrounding tissues (Sfanos et al. 2017) (Figure 2). This 
results in further inflammatory response, perhaps resulting in a self-perpetuating 




Figure 2. Prostatic inflammation induced by epithelial barrier breach. 
Depicted on the left image is a normal prostatic gland with proposed microorganisms in 
the prostatic secretions. As foreign bacteria enter the prostate via urinary reflux, toxins 
are produced which cause inflammation and distortion of the epithelial tissue. The right 
image shows the resulting disruption that may allow microorganisms to leave the lumen 
and enter the stroma to cause further inflammation (Sfanos et al. 2017). Text not inteded 







Detection and Treatment 
Prostate cancer is the most frequently diagnosed cancer in American men 
(Dhanasekaran et al. 2001). Although prostate cancer tends to be localized and 
unlikely to result in patient death, screening for prostate cancer is not well 
optimized to differentiate between indolent and aggressive carcinoma (Kooh et 
al. 2019). As prostate cancer progresses and metastasizes to distant tissues and 
structures, the likelihood of curing the cancer decreases (Leeuwen et al. 2019). 
This places the screening process as a pivotal determinant to confirm the 
presence/severity of cancer. Different methods to screen for prostate cancer are 
used, such as testing for elevated prostate specific antigen (PSA), digital rectal 
exam (DRE), and MRI imaging.  
PSA screening is a blood-based biomarker that tests for enzymes produced 
almost exclusively by the prostate gland (Koo et al. 2019). Although screening for 
PSA allows for early detection, elevated PSA levels may also be present in non-
malignant pathological conditions such as benign prostatic hyperplasia (BPH) as 
well as prostatic inflammation (Dhanasekaran et al. 2001). Lately, using PSA as a 
cancer screening biomarker has been known to provide false-negative and false-
positive diagnoses (Koo et al. 2019). With the unreliability of PSA testing as a 
diagnostic tool, patients are placed at risk to be over-biopsied for cancer that they 
do not have or over-treated for a cancer that would never have killed them (Koo 
et al. 2019). 
Patients with positive PSA screening tests will be referred for a surgical 
biopsy to further confirm cancer diagnosis. When performing a biopsy on the 
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prostate, the surgeon may use one of many procedures depending on the patient’s 
condition and the healthcare provider’s practices such as: the transrectal method, 
the perineal method, and the transurethral method (Johns Hopkins Medicine, 
2020). The biopsy relies on removing prostate tissue samples from regions 
associated to the patient’s proposed cancer location(s). “[While] the detection of 
prostate cancer in the biopsy ranges from 25% to 48%, this rate decreases 
between 10% and 25% in the case of repeat biopsy,” (Karakiewicz et al. 2018).  
MRI imaging is becoming a more commonly used tool in the cancer 
screening process. Typically, patients may receive MRI scans if the health 
provider decides to complete further conclusive tests after biopsy results (NIHR, 
2017). Although MRI scans are a new valuable asset for prostate cancer detection, 
MRI findings may not always provide accurate results in patients with previous 
negative biopsies (Karakiewicz et al. 2018).  
Radical prostatectomy, or complete surgical removal of the prostate, is a 
widely performed procedure to treat prostate cancer. Though radical 
prostatectomy is the most common procedure for men diagnosed with prostate 
cancer, surgery is associated with small long-term reductions in mortality and 
increases of life gained (Wilt et al. 2020). Radical prostatectomy can be used to 
cure locally confined prostate cancer, but the likelihood of curing the patient 








This project focused on the visualization of a new proposed pathway of 
development of prostate cancer precursor lesions through three main objectives: 
 
1. Create 3D models and motion graphics using a third-party rendering 
engine. 
2. Design a short animation that contextualizes recent evidence on 
prostate cancer precursor lesion development using computer graphics 
imaging and novel histological data.  
3. Communicate the new proposed hypothesis to researchers that 
specialize in oncology.  
 
Audience 
 The primary audience for this animation is cancer researchers that do not 
specialize in prostate cancer research. These individuals are well versed in cancer 
research, but have little exposure or knowledge of prostate cancer development. 
This project can also be used by a secondary audience of graduate students with 







MATERIALS AND METHODS 
 
Software Overview 
 A number of digital programs and software plugins were used to create 
storyboards, record audio, build 3D models, animate, and composite the renders. 
Adobe Photoshop CC 2020®, Adobe After Effects CC 2020®, Adobe Audition CC 
2020®, Pixologic ZBrush®, Maxon Cinema 4D R20®, Redshift® for Cinema 4D.  
Adobe Photoshop CC 2020 was used to create storyboards for the 
preliminary animation. Adobe After Effects CC 2020 was used for compositing 
images from Photoshop for the preliminary animation, known as the animatic, as 
well as the final compositing for the final renders created by the 3D software. 
Adobe Audition CC 2020 was used for recording and editing the audio for the 
animatic and final animation. Through Pixologic ZBrush, complex meshes and 
geometry were created that were otherwise difficult to create in Cinema 4D R20. 
Cinema 4D R20 was used to create 3D models, manipulate 3D models, and add 
motion graphics. Redshift for Cinema 4D, a third-party plugin, was used as the 
rendering engine to create quick preview renders, adjust lighting, materials, 
increase rendering efficiency, and used to generate the final renders.  
 
Content Aggregation 
 Research from The Sfanos Laboratory was obtained in the form of 
publications and novel histological prostatectomy data. The first titled, ‘The 
Inflammatory Microenvironment and Microbiome in Prostate Cancer 
Development’ (Sfanos et al. 2017).  The second publication titled ‘Inflammation 
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in Prostate Carcinogenesis’ (De Marzo et al. 2007). The third is titled ‘Prostate 
Cancer’ (Nelson et al. 2012). These publications provided a general overview of 
understanding the development of prostate cancer within the context of chronic 
inflammation and the microbiome. Along with these publications were 
histological slides depicting the progression and development of the risk factor 
lesions that are believed to be progenitors for prostate cancer. Additional 
information and data were gathered from related publications to the topic.  
 
Script and Narration Development 
 For visualization of the prostate cancer precursor lesions, a script was 
developed to focus on the histological findings from The Sfanos Laboratory. The 
script covered the method in which pathologists commonly study the prostate, 
the techniques used to stain the prostate specimens, and the significance of these 
new findings. Careful wording was used to appropriately describe complex topics 
within the proposed pathway to better communicate this unfamiliar hypothesis to 
the intended audience. The script was narrated and the audio was recorded to 
then edit in Adobe Audition CC 2020. 
 
Storyboard Development 
 A storyboard was created to act as the preliminary animation to the final 
3D animation. In order to create the storyboard, Adobe Photoshop CC 2020 was 
used to draw 2D representations of scenes and models to create in the various 3D 
programs.  
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 The storyboard was edited a total of three times prior to becoming 
finalized. Feedback from the Principal Investigator of The Sfanos Laboratory 
was used for revisions. After the 2D stills from Adobe Photoshop CC 2020 were 
approved, the animatic was created and the edited audio from Adobe Audition CC 
2020 was inserted to adjust the timing between the words and the visuals. 
 
3D Asset Creation 
 
Creating a Prostate in Zbrush 
 
The introduction to the animatic composed of a 3D representation of the 
adult prostate with its accompanying sectioning is similar to the method used by 
pathologists when studying prostatic tissue. Using measurements and 
photographic dissection references supplied by the Principal Investigator of The 
Sfanos Laboratory, the prostate was digitally sculpted with the 3D sculpting 
program Pixologic ZBrush. A Zbrush subtool in the form of a sphere was used as 
the preliminary shape for sculpting the prostate (Tool > Sphere3D). After 
selecting the sphere subtool, the sphere was dragged onto the canvas and the 
sculpting cursor was changed from Draw to Edit. Photographic references and 
measurements were then used to deform the sphere using the Move 
Topological Brush preset. Once the sphere mesh was deformed to an adequate 
shape of a normal adult prostate, the mesh needed to be re-topologized to 
account for the stretched polygons was caused by the Move Topological Brush 
(Figure 3). The mesh was re-topologized using ZRemesher and occasionally 
adjusted with the Target Polygons Count drag bar. This process was repeated 
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Figure 3. Anterior view of the prostate model. The prostate form is 
sculpted in ZBrush after using the Move Topological Brush.  
 
Next, the prostatic urethra and the paired ejaculatory ducts that course 
through the prostate were sculpted. Histological cross sections were used as 
reference material for the approximate location of the prostatic urethra and 
ejaculatory ducts. In order to create these channels within the prostate, 
cylindrical meshes were imported onto the canvas and appended as new subtools. 
With the urethra subtool selected, the mesh was subdivided for clean 
manipulation of the topology without creating jagged edges (Geometry > 
Subdivide). The topology for the urethra was limited to a mesh consisting of less 
than five hundred thousand ActivePoints to reduce the complexity and memory 
size of the final prostate model for exporting/importing. The prostatic urethra 
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mesh was also well controlled using ZRemesher to retain clean and even 
topology after each drastic manipulation of the mesh. The shape for the prostatic 
urethra was manipulated by pushing and pulling the geometry using the 
Standard Brush and the Move Topological Brush from the Brush Palette. 
Once the adequate size, shape, and positioning of the urethra were achieved, the 
mesh was combined to the prostate and subtracted using Live Boolean. The 
urethra subtool was moved below the prostate subtool in the Subtool Palette and 
the appropriate Boolean Subtract icon was turned on to subtract the second 
subtool from the previous subtool in the Subtool Palette (Boolean > Make 
Boolean Mesh). Afterwards, a new tool was generated as the end product of the 
urethra subtraction from the prostate, leaving a channel within the prostate. The 
new combination of prostate and urethra was introduced to the subtool palette 
for the creation of the ejaculatory ducts (Append > UMesh_Postate).  
To create the ejaculatory ducts, a cylinder was sculpted and manipulated 
in the same fashion as the prostatic urethra. After the ejaculatory duct for one 
side was finished, the subtool was duplicated and mirrored to create an exact 
copy of the subtool for the opposing duct (Zplugin > SubTool Master > 
Mirror > Select: Merge into one SubTool & X axis).  
The prostate model, with the new prostatic urethra and two ejaculatory 
ducts, was then sculpted further to simulate the texture and form of an actual 
human prostate (Figure 4). Using the polygon subdivision command (Ctrl + D), 
the prostate mesh was taken to an ActivePoints count of less than one million 
polygons to reduce the exporting size of the mesh kept at a high ActivePoints 
count to retain fine sculpting details. The Standard Brush was used to digitally 
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sculpt the prostate model in combination with a custom Alpha channel by 
dragging a black and white polygon displacement map over large areas one at a 
time (Alpha > [Choose desired alpha channel]). This technique resulted in 
realistic prostatic tissue similar to prostatectomy specimens seen in the provided 
pathology photographs (Figure 2). After sufficient texturing was completed, the 
prostate model was exported as an OBJ file (Export [SubTool Palette] > Save as 
format: OBJ). 
 
   
Figure 4. Boolean Subtraction and prostate texturing methods. The 
model is shown after meshes were created for subtraction as well as alpha brush 
sculpting. (A) Oblique anterior view of meshes for prostatic urethra and 








 The next scene in the animation displayed the prostate sliced, similar to 
the method used by pathologists to study the prostate under a microscope. To 
separate the prostate into multiple slices, Boolean subtraction was used in 
combination with re-topologizing techniques. Pathologists transversely dissect 
the prostate into six to ten slices depending on the size of the prostate. Eight 
rectangular prisms were appended to the Subtool Palette and were evenly spaced 
in the Y-axis of the model (Append > PM3D_Cube3D). Each rectangular 
prism was subdivided to ensure equal ActivePoints with the prostate mesh (Ctrl 
+ D) and then subtracted from the previous rectangular prism to ‘slice away’ the 
previous mesh. Once the new combined Boolean mesh was created, the resulting 
subtool was saved as a new ZPR file and used for the next slice (Figure 5). This 
process was repeated seven more times to complete the remaining slices. 
 
 
Figure 5. Sectioning the prostate model. The prostate model with the seven 
Boolean Subtraction rectangular prisms for slicing. 
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Once the desired slice thickness was achieved, each ZPR file was saved and 
sculpted separately to simulate the texture of stroma when the prostate is sliced 
open. Prior to texturing the stromal surface, the prostate slice was re-topologized 
to remove any broken geometry caused by the Boolean subtraction (Geometry > 
ZRemesher > ZRemesher). The new polygon count for each slice was kept 
under seven hundred thousand ActivePoints (ZPlugin > Decimation Master 
> Pre-process Current > Decimate Current). Boolean subtraction created 
more polygons to the prostate model and added fourteen new planar surfaces in 
between each slice, thus requiring additional polygon reductions to keep the size 
of the file as small as possible. It was crucial to not manipulate the coordinate 
location of the prostate slices as it would be very difficult to realign the slices to 
the correct X, Y and Z-axis from which they were Boolean subtracted. The eight 
slices were then separately exported as OBJ files to animate in C4D (Export 
[SubTool Palette] > Save as format: OBJ) (Figure 6). The slices were then 






Figure 6. Resulting prostate slice from Boolean Subtraction. The model 
shown is of a slice of prostate after the completed Boolean Subtraction method 
along with stromal texturing created with the use of an alpha channel brush.  
 
 
Figure 7. Redshift Material application. Redshift material nodes showing 
procedural creation. Text not intended to be read. 
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To provide the orientation and location of the prostate, an adult male 3D 
body model was created. A premade project of the male figure was imported onto 
the canvas in ZBrush to accelerate the process of modeling the male silhouette 
(LightBox > Project > DemoProjects > SuperAverageMan.ZPR). Using 
this basic mesh, additional steps were required to adequately intigrate the mesh 
into the animation. The preliminary animation consisted of zooming into the 
prostate in the pelvis, but the male body mesh had all extremities modeled which 
were of little importance to the location of the prostate. Using Boolean 
subtraction, two large rectangular prisms were appended into the Subtool Palette 
and were resized and relocated to cover the arms, head, and legs (Append > 
PM3D_Cube3D1). Before Boolean subtracting the rectangular prisms from the 
male body, the surface subdivisions were increased for the male body and the 
rectangular prisms with equal ActivePoints for all three meshes (Ctrl + D). These 
ActivePoints values were kept approximately equal to preserve even geometry 
through the Boolean subtraction process. Once appropriate placements of the 
rectangular prisms were completed, the meshes were combined leaving the male 
abdomen, pelvis, and thighs, as one mesh (Boolean > Make Boolean Mesh). 
To redistribute even topology and to reduce ActivePoints size, ZRemesher was 
used with a combination of subdividing the mesh as needed (Ctrl + D; 
Geometry > ZRemesher > ZRemesher). After the geometry was uniform 
and re-topologized, the male body was exported as an OBJ file (Export [SubTool 




Prostate Gland and Luminal Epithelium 
 
 The following scene was staged in the lumen of a prostatic duct where the 
camera dives into the peripheral zone of the prostate slice on screen. To create a 
three-dimensional representation of the prostatic duct, histological slides were 
used as primary reference material. In Cinema 4D, six circle splines were loaded 
onto the scene and distanced relatively equal distances from one another to 
create the shape of a tube. The Loft generator was used to form 2D geometry 
connecting all six circle splines. The six splines were placed under the Loft 
generator as ‘children’ and a continuous tube was created and used as the 
backbone of the lumen. Next, subdivision surface was used to increase the 
polygon count and overall smoothness of the tube geometry (Figure 8).  
 
 
Figure 8. Creation of the prostate gland. Six splines connected to create a 
continuous tube.  
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To add organic form to the tube, all of the items on the object list were combined 
and turned to editable geometry (Right Click > Connect Objects and 
Delete). The sculpting package of Cinema 4D was used to distort the tube into 
the organic form of a prostate gland) (Figure 9).  
 
 
Figure 9. Modifying the lofted tube with Move in Cinema 4D. The 
viewport appearance of the manipulated editable tube. 
 
After the desired shape of the lumen was achieved, spheres were added to 
simulate individual luminal epithelial cells. A sphere object was placed into the 
scene and was scaled at an appropriate size in comparison to a gland (T + Left 
Click + Drag Up/Down on Screen. The polygon count for the sphere to be 
cloned was reduced to allow easier Viewport manipulation. A Cloner Object was 
used to duplicate one hundred and sixty thousand clones of the sphere 
throughout the surface of the lumen mesh (Figure 10). The spheres were sized 
and distributed randomly to replicate the uneven surface of the lumen. Due to 
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random distribution of the clones, bare areas of the tube were seen with large 
gaps in between each sphere. In all visible bare areas, spheres were manually 
placed in small clusters to cover them from being seen from the camera. After all 
visible areas were covered, all of the objects in the object list were combined into 
one object (Select All Objects in Object List > Right Click > Connect 
Objects and Delete) A Redshift material with subsurface scattering was used to 
add texture to the luminal epithelial cells lining the lumen of the prostatic gland 












Figure 10. Cloning spheres to create individual luminal epithelium. 
The result of cloning one hundred and sixty thousand spheres onto the deformed 








Modeling Bacteria in Cinema 4D 
 
As the animation progressed, bacteria were seen swimming through the 
lumen of the prostatic gland. The bacteria chosen to be represented within the 
prostate was E. coli due to the fact that this strand of bacteria is commonly seen 
within the adult prostate. In Cinema 4D, a pill primitive was imported onto the 
scene and the height, width, rotation segments, and height segments were 
adjusted to create the appropriate dimensions of an E. coli bacterium. E. coli 
electron microscopy images were used as reference to depict accurate dimensions 
(Figure 12).  
 
 
Figure 12. Viewport of the edited pill object in Cinema 4D. This viewport 
image shows the proportioned shape of the E. coli bacteria after referencing 




Figure 13. Material node for E. coli. Hierarchy of the shader graph in 
Cinema 4D showing Redshift material creation. Text not intended to be read.  
 
To create cellular surface texture, a Redshift material was assigned to the 
pill object (Create > Redshift > Materials > Material). In the Redshift 
material, nodes were placed into the shader graph and adjusted to create a blue 
subsurface scattering material (Figure 13). Small hairs on the surface of the E. 
coli bacterium were also created to represent the small pili and flagella seen 
under the microscope. Using Redshift, a hair material was added to the object to 
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create small randomized hairs throughout the entire surface of the object 
(Create > Redshift > Materials > Hair Material). Once the hairs were 
created, the hair splines were swept using the Sweep generator and a circle spline 
with a very small radius. Turbulence and Friction MoGraph Effectors were 
linked to the hair materials to add kinks and frizzy characteristics (MoGraph > 
Effector > Turbulence; MoGraph > Effector > Friction) (Figure 14). The 
same subsurface scattering material node used for the body of the E. coli was 
added to the hair materials for the pili and flagella (Figure 15). 
 
 
Figure 14. Screenshot of hair shader graph in Cinema 4D for pili and 
flagella. Text not intended to be read. 
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Figure 15. Rendered frame of E. coli in Cinema 4D using Redshift 
materials. 
 
Creating Immune Cells 
 
 Immune cells appeared in the following scenes to depict chronic 
inflammation, so they were then modeled and animated. Creation of the immune 
cells began with creating a sphere primitive in Cinema 4D. The surface of the 
sphere was manipulated to create small bumps and distortions as seen in electron 
microscopy images. A total of three immune cells were created: macrophage, 
monocyte, and neutrophil. Once the rough shape for the immune cells were 
completed, the surface was further textured using a custom Redshift material. 
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This method would produce results with fewer polygons to prevent any delays or 
lag in the viewport. 
 
Adjusting the Camera and Lighting in Cinema 4D 
 
Next, the default camera in Cinema 4D was rigged to become an easily 
controllable and adjustable object within the scene. First, a Target Tag was 
applied to a Redshift Cinema 4D Camera (Redshift > Cameras > Standard; 
Tags > Cinema 4D Tags > Target). The target chosen for the Target Tag was a 
Null object. A horizontal circle spline was used as the rotation for the camera rig. 
User Data was activated on the Null Object to create Float Sliders to adjust the 
target height, distance, rotation, Move X, Move Y, and Move Z of the camera rig. 
The camera rig User Data was dragged onto the Expressor Editor and the node 
options for the target height, distance, rotation, Move X, Move Y, and Move Z 
were added to the User Data node. The corresponding nodes of the camera rig 
were then linked to the circle spline and the Target Tag to control the positions 
via sliders in the User Data. The camera was keyframed for each scene according 
to the approved animatic.  
To light the scenes, Redshift lights were used in combination with default 
Cinema 4D lights (Redshift > Lights > Area Light/Dome Light). Models 
were animated using deformers and then keyframed in Cinema 4D. After the 
scenes were rendered using Redshift, the frames were saved as PNG sequences 
due to their small size and lossless characteristics. The PNG sequences were then 
imported into Adobe After Effects for compositing the frames into a moving 
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animation. Further color adjustments, time stretching, and transitions were 


























Animation Storyboards and Rendered Stills 
 A set of black and white storyboards (Figures 16-33) were developed in 
Photoshop to portray the 3D animation in a 2D format, also known as the 
animatic. The animatic would serve to develop the imagery being displayed as 
well as the pacing of the narration.  
 The final animation video file was 3 minutes and 55 seconds in length 






















Figure 18. The prostate is sectioned into several slices to portray the method 




Figure 19. One slice of the prostate remains as the other slices are removed 




Figure 20. Single slice is oriented to be parallel to the camera and then divided 




Figure 21. One quadrant of the slice remains and the three remaining slices are 
removed from the scene.  
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Figure 22. A single quadrant of the slice is brought close to the camera and  is 













Figure 25. Immune cells detect the presence of E. Coli and begin to mobilize 
into the lumen. 
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Figure 26. As immune cells travel into the lumen, they release cytokines to alert 
nearby immune cells of invading bacteria. Reactive oxygen species are also 
actively released by the immune cells during this time. 
 
 
Figure 27. As bacteria travel through the prostate gland, they release toxins that 




Figure 28. The camera pans towards luminal epithelium as reactive oxygen 




Figure 29. A 2D schematic of the luminal epithelial cell’s DNA depicts the 




Figure 30. The camera then goes back to the cell absorbing the reactive oxygen 




Figure 31. The small atrophic cell then begins to divide and push away normal 
luminal epithelial cells. 
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Figure 32. As the viewer zooms out from the small cluster of atrophic epithelial 




Figure 33. A cross-section of the atrophic lesion is made visible as the camera 
moves away from the lumen. A histological microscope slide of an ERG+ lesion 
will fade onto this 3D modeled scene.  
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Figure 39. Animation still. Viewer is within a prostatic gland. 
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Figure 43. Animation still. Mutated luminal epithelial cell becomes atrophied 
and divides uncontrollably.  
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Access to Assets 
Access to the animation from this thesis can be viewed at 
http://labs.pathology.jhu/sfanos/ and  https://plasmavisuals.com/. The 
author may be reached through the website of the Department of Art as 


























 The primary goals of this project were to fill a visual void in 
communicating pathological prostate cancer data and to create a 3D animation to 
visualize a proposed mechanism of disease for precursor lesion development. 
Another goal was to illustrate the didactic method of using novel histological 
datasets within a 3D animation to effectively understand 2D microscope slide 
evidence. The results of this project were intended to educate graduate students, 
prostate cancer researchers, and non-prostate cancer researchers by providing a 
didactic visual to understand this new hypothesis.  
 
Challenges Encountered During the Project 
The goal of the animation was to communicate a visually challenging 
proposal to an audience that were non-prostate specialists. This proved 
challenging in regards to writing a narrative that succinctly explains the role of 
the microbiome within the context of chronic inflammation within the prostate to 
researchers with little familiarity to the prostate. Initially, a script for the 
animation was developed that exceeded four and a half minutes.  
Another challenge faced during the completion of this animation was the 
limited computing power needed to render the final animation. When rendering 
through Cinema 4D, computer generated images are calculated using the 
computer processing unit (CPU). Cinema 4D rendering is a multi-threaded 
process that uses cores in the computer’s CPU. Rendering on the department 
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Apple iMac with a CPU that has 4 cores using Cinema 4D’s built-in Physical 
rendering engine is time consuming and would have taken over three weeks to 
render the final animation. Redshift, a third-party rendering engine for Cinema 
4D, was chosen for its optimized rendering times. Redshift has the capability to 
render 3D computer generated images by using the graphics processing unit 
(GPU) of the computer instead of the CPU. To use Redshift, the computer must 
have: a minimum of 8GB of system memory, Windows OS 7/8/10 64-bit or 
MacOS Sierra, and a NVidia GPU (which is no longer supported on MacOS after 
High Sierra OS) with CUDA compute capability 6.0 or higher with 8GB of VRAM. 
VRAM, or video random access memory, is typically used to store image data that 
is displayed by the computer, but can also be used for accelerated biased 
rendering when using 3D graphics programs. To use Redshift, a computer with 
the necessary specifications was built. The graphics processing units chosen were 
two ASUS ROG Strix GeForce RTX 2080 ti models with 11GB of VRAM each. 
This amount of GPU VRAM allowed me to use Redshift in Cinema 4D to 
efficiently render the 3D animation.  
 
Accessibility 
To further educate audiences within the research field, this animation will 
be accessible on the Johns Hopkins Medicine Pathology: The Sfanos Laboratory 
webpage. The user can revisit the website at their own leisure to view the 3D 
animation. At the end of the animation, a list of references will be provided for 
the viewer to review. The animation will be posted on YouTube and then linked 
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onto The Sfanos Laboratory’s website. This will allow the animation to use 
closed captions for viewers that prefer to read subtitles.  
 
Future Directions  
With the completion of the 3D precursor lesion development animation, 
the viewer will have a clear understanding of the new hypothesis for prostate 
cancer in the context of bacterial infection and chronic inflammation. The next 
step for this project is to delve deeper into each biological and cellular process 
that were briefly stated in the animation. By representing these complex and 
visually challenging molecular topics, viewers will be provided with more 


















After viewing the 3D animation, the viewer will: 
• Recognize histological structures of the prostate. 
• Visualize novel cancer datasets from prostatectomy specimens. 
• Understand the proposed development pathway for prostate cancer 
precursor lesions. 
• Identify the suspected contributors to prostate cancer. 
• Understand the resulting luminal epithelium disruption caused by 
supposed epithelial cellular mutations.  
• Comprehend the importance of the microbiome within the prostate. 
















“Visualizing Prostate Cancer Precursor Lesion Development” Script 
 
 
Prostate cancer is one of the most common malignant neoplasms among men in 
western countries. The only known risk factors for prostate cancer are advanced 
age, family history, and African ancestry. Genetics, diet, and other lifestyle-
related factors may also play a role. Recently, chronic inflammation has been 
linked to the growth and development of several solid cancers and may 
contribute to prostate carcinogenesis.  
 
Studying the histology of the prostate offers pathologists valuable insights into 
the possible pathogenesis of prostate cancer. Within the prostate, are small 
compound tubular alveolar ducts known as: prostatic glands. These glands are 
made of pseudostratified columnar luminal epithelial cells and simple squamous 
basal cells, surrounded by a stroma of connective tissue and smooth muscle.  
 
In a normal prostate, the glandular luminal epithelial cells have very low cellular 
turnover and rarely proliferate. Inflammation in the prostate is associated with 
the development of proliferative inflammatory atrophy (PIA), a proposed 
precursor lesion to prostate cancer development. Unlike normal prostatic 
epithelial cells, luminal cells involving PIA have high cellular turnover and are 
highly proliferative.  
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As foreign bacteria invade the glands, immune cells such as neutrophils, 
macrophages, and monocytes, quickly begin to populate the lumen and release 
cytokines. This inflammatory state drives immune cells to produce reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) that may cause DNA 
damage and DNA breaks. In addition, the invading bacteria can produce 
genotoxins, such as colibactin present in E. coli, that may also induce DNA 
damage in luminal epithelial cells. 
 
When inflammatory oxidants and/or bacterial genotoxins leads to DNA breaks, 
abnormal gene fusions may result. Transmembrane protease serine-2 
(TMPRSS2) is a protein regularly expressed and driven by androgen receptor 
signaling within the luminal cells of the prostate. Along the same chromosomal 
strand of DNA is the gene for erythroblastosis virus E26 oncogene homolog 
(ERG), a known oncogene. In normal functioning luminal epithelial cells, ERG is 
not expressed. However, recent evidence has shown that in about 50% of prostate 
cancer cases in the US, the promoter region of the TMPRSS2 gene has become 
fused to the coding region of the ERG gene; causing cells to express the ERG 
oncoprotein. It is hypothesized that genomic damage caused by infections and 
inflammation promote the formation of the TMPRSS2:ERG gene fusion, possibly 
playing a very early and not yet well understood role in the development of 
prostate cancer.  
 
The ERG expressing cells replicate and displace the Erg negative luminal 
epithelial cells in the PIA lesion. These atrophic cells release pro-inflammatory 
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cytokines and other acute inflammatory proteins to further increase immune cell 
count within the glands. At some point, perhaps with the acquisition of additional 
genomic and/or epigenomic alterations, these Erg expressing cells invade the 
basement membrane. Once the luminal cells infiltrate the stroma, the basal cells 
are no longer maintained, and the Erg expressing cells are now consistent with 
prostate adenocarcinoma. These cancer cells then form smaller irregular glands 
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